Clinical Trials
4 trialsNCT05139095 2026-02-05
Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT06790706 2025-10-06
IMMUNORARE5
Hospices Civils de Lyon
Phase 2 Recruiting
NCT06020755 2024-12-31
TA7
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT05635344 2024-04-17
A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia
Imperial College London
Phase 2 Recruiting